Garofalo Health Care S.p.A. (BIT:GHC)

Garofalo Health Care Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	462.18	360.98	314.76	277.87	206.78
Other Revenue	8.53	5.16	5.28	5.06	1.56
Revenue	470.71	366.14	320.04	282.93	208.34
Revenue Growth (YoY)	28.56%	14.40%	13.12%	35.80%	7.19%
Cost of Revenue	368.95	285.45	251.39	222.42	169.09
Gross Profit	101.76	80.69	68.65	60.51	39.24
Selling, General & Admin	-	0.89	0.83	0.67	0.46
Other Operating Expenses	31.47	14.47	13.74	11.74	10.22
Operating Expenses	57.63	36.8	32.93	27.93	22.27
Operating Income	44.13	43.88	35.72	32.58	16.97
Interest Expense	-14.77	-10.29	-4.2	-4.21	-2.54
Interest & Investment Income	-	0.28	0.02	0	0
Earnings From Equity Investments	0.12	0.17	0.13	0.21	0.23
Other Non Operating Income (Expenses)	1.2	-0.46	-0.24	-0.25	-0.16
EBT Excluding Unusual Items	30.69	33.58	31.43	28.34	14.5
Gain (Loss) on Sale of Assets	-	0.08	0.14	0.06	0.03
Asset Writedown	-	-1.67	-0.6	-0.19	-0.22
Legal Settlements	-	-2.39	-3.78	-2.73	-3.17
Other Unusual Items	-	-0.7	-	-	1.88
Pretax Income	30.69	28.93	27.37	25.48	13.02
Income Tax Expense	8.84	8.06	5.94	6.63	1.24
Earnings From Continuing Operations	21.85	20.87	21.43	18.84	11.78
Minority Interest in Earnings	-0.15	-0.07	-0.01	-0.01	-0
Net Income	21.7	20.8	21.43	18.83	11.78
Net Income to Common	21.7	20.8	21.43	18.83	11.78
Net Income Growth	4.34%	-2.93%	13.76%	59.87%	-10.36%
Shares Outstanding (Basic)	90	89	89	89	82
Shares Outstanding (Diluted)	90	89	89	89	82
Shares Change (YoY)	2.11%	-0.40%	-0.37%	9.34%	-0.12%
EPS (Basic)	0.24	0.23	0.24	0.21	0.14
EPS (Diluted)	0.24	0.18	0.24	0.21	0.14
EPS Growth	33.33%	-25.00%	14.29%	50.00%	-12.50%
Free Cash Flow	16.7	34.57	30.04	13.12	11.97
Free Cash Flow Per Share	0.18	0.39	0.34	0.15	0.15
Gross Margin	21.62%	22.04%	21.45%	21.39%	18.84%
Operating Margin	9.37%	11.98%	11.16%	11.52%	8.15%
Profit Margin	4.61%	5.68%	6.69%	6.66%	5.66%
Free Cash Flow Margin	3.55%	9.44%	9.38%	4.64%	5.75%
EBITDA	69.46	61.6	54.09	48.1	28.56
EBITDA Margin	14.76%	16.83%	16.90%	17.00%	13.71%
D&A For EBITDA	25.33	17.72	18.36	15.52	11.59
EBIT	44.13	43.88	35.72	32.58	16.97
EBIT Margin	9.37%	11.98%	11.16%	11.52%	8.15%
Effective Tax Rate	28.80%	27.85%	21.69%	26.04%	9.51%
Revenue as Reported	470.71	368.7	322.58	283.67	210.85

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.